Free Lesson Preview
This is just the beginning
The full CRC track covers 8 courses from study start-up to close-out β the skills sponsors actually look for.
View enrollment optionsAlready enrolled? Sign in
Clinical Research Coordinator
Full course Β· Safety Reporting and Pharmacovigilance for CRCs
Free Lesson Preview
The full CRC track covers 8 courses from study start-up to close-out β the skills sponsors actually look for.
View enrollment optionsAlready enrolled? Sign in
Define the CRC's specific safety reporting responsibilities and the critical boundaries between the CRC, investigator, sponsor, and IRB roles.
It is Friday at 4:47 p.m. The coordinator's phone rings. A participant enrolled in a Phase III trial is calling to report that she was admitted to the hospital the previous night with chest pain. She is stable now, speaking from her hospital bed, but she wants the study team to know.
In the next 24 hours, five people must act. The coordinator must gather the initial details and begin documentation. The investigator must provide a medical assessment of seriousness and causality. The sponsor must receive the initial report within the timeline specified in the protocol. The IRB must be notified per institutional policy. And the participant herself must be monitored and, if necessary, have her consent re-evaluated in light of new safety information.
The chain has a beginning, and that beginning is the coordinator's response to the phone call. Not the investigator's medical judgment -- that comes second. Not the sponsor's aggregate analysis -- that comes third. The coordinator's ability to recognize what has happened, document it accurately, and set the reporting chain in motion determines whether everything downstream proceeds correctly and on time.
This lesson defines exactly where the coordinator's role begins, where it ends, and why those boundaries matter as much as the responsibilities themselves.
Progress saves itself β finish reading and this lesson completes